Wedbush Reviews Fennec Pharmaceuticals' Q4
In This Article:
Fennec Pharmaceuticals' fourth-quarter Pedmark revenue of US$7.9 million beat Wedbush's US$7.6 milli
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.